...
首页> 外文期刊>Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association >Proliferative glomerulonephritis with monoclonal IgG deposits secondary to chronic lymphocytic leukemia. Report of two cases.
【24h】

Proliferative glomerulonephritis with monoclonal IgG deposits secondary to chronic lymphocytic leukemia. Report of two cases.

机译:增生性肾小球肾炎,继发于慢性淋巴细胞性白血病的单克隆IgG沉积物。报告两例。

获取原文
获取原文并翻译 | 示例
           

摘要

Proliferative glomerulonephritis with monoclonal IgG deposits (PGNMID) is a recently described entity that is only rarely associated with a hematological or lymphoproliferative malignancy. We describe the cases of two men with preexisting chronic lymphocytic leukemia (CLL) who developed endocapillary proliferative glomerulonephritis with nonorganized monoclonal IgG(1) deposits. One biopsy also showed CLL infiltration of the cortex. Both patients were treated with rituximab in addition to cyclophosphamide in one case and fludarabine in the other with significant improvement of their renal disease and CLL. This report provides additional evidence to support the use of rituximab in the therapy of CLL-associated PGNMID.
机译:具有单克隆IgG沉积物(PGNMID)的增生性肾小球肾炎是最近描述的一种实体,很少与血液学或淋巴增生性恶性肿瘤相关。我们描述了两名患有慢性淋巴细胞性白血病(CLL)的男性患者的案例,这些患者发展出无组织单克隆IgG(1)沉积的毛细血管内增生性肾小球肾炎。一项活检还显示CLL浸润了皮质。两名患者除环磷酰胺和氟达拉滨外,还分别用利妥昔单抗和氟达拉滨治疗,均显着改善了肾脏疾病和CLL。该报告提供了其他证据来支持利妥昔单抗在CLL相关性PGNMID治疗中的应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号